P2 was suspended in 10 vol of 0.32 M sucrose and 10 ml of the solution layered on a 0.8 and 1.2 M two-step discontinuous gradient, which was centrifuged at 61,000 x g for 2 h to separate the synaptosomes from the mitochondria (which forms the pellet)
Comments are due July 22, 2026, and anything the agency wants in the briefing book for its Pharmacy Compounding Advisory Committee needs to land by July 9
-cell resistance to glucagon-like peptide 1 (GLP-1) contributes to progressive failure in the function of -cells [7]
Here's what the science says Hims, a San Francisco-based telehealth company, had capitalized on this drug shortage by developing copycat compounded versions of the medications, as permitted by the FDA
GLP-1 medicines incorporating GIPR blockade, like maritide, also show promise